Literature DB >> 2686056

Essential blepharospasm and related dystonias.

D R Jordan1, J R Patrinely, R L Anderson, S M Thiese.   

Abstract

Essential blepharospasm is an idiopathic disorder of progressive involuntary spasms of the orbicularis oculi and upper facial (corrugator, procerus) muscles. Blepharospasm literally means spasm of the eyelids; however, most patients with blepharospasm also have or will develop squeezing in the lower face and neck muscles (Meige's syndrome, orofacial dystonia, or oromandibular dystonia). Some patients develop dystonic, uncontrolled movements in areas outside the facial nerve distribution (segmental cranial dystonia or craniocervical dystonia). Chronic, forceful squeezing by the periocular muscles becomes debilitating for the patient and leads to functional and cosmetic eyelid deformities. Treatment has included a variety of modalities and oral medications that are of limited efficacy. Botulinum-A toxin injections have delivered the best temporary relief from this disorder, while the periorbital myectomy operation has been shown to give the best long-term results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686056     DOI: 10.1016/0039-6257(89)90040-4

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

1.  Dry eye and Meige's syndrome.

Authors:  K Tsubota; T Fujihara; M Kaido; A Mori; M Mimura; M Kato
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 2.  Neuro-ophthalmologic complications and manifestations of upper and lower motor neuron facial paresis.

Authors:  M Tariq Bhatti; Jade S Schiffman; Anastas F Pass; Rosa A Tang
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

3.  Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.

Authors:  J A Mauriello; J Aljian
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

4.  Surgical management of essential blepharospasm.

Authors:  A K Bates; B L Halliday; C S Bailey; J R Collin; A C Bird
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

5.  Injecting botulinum toxin into the treatment of blepharospasm.

Authors:  Marius Nicolae Popescu; Stella Ioana Popescu; Corina Cristina Cernat; Ana Maria Boariu; Edward Călin; Ana Vieru; Ovidiu Muşat
Journal:  Rom J Ophthalmol       Date:  2018 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.